Manish C. Choudhary - Concepedia

Author

Manish C. Choudhary

Also Known As

Bharat Mocherla, Coombs, Robert W., Currier, Judith S., Daar, Eric S., Fletcher, Courtney V., Keila Hoover, M Choudhary, M. Choudhary, M.C. Choudhary, Manish C. Choudhary

107

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

Harvard University Brigham and Women's Hospital Massachusetts General Hospital Ragon Institute of MGH, MIT and Harvard Broad Institute

About

Manish C. Choudhary is an author at Harvard University specializing in medicine, virology, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	1.8K
2	Epidemiology	6	6	1.1K
3	Public Health	4	4	1K
4	Natural Sciences	1	1	17
5	Global Health	1	1	21

Manish C. Choudhary

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
SARS-CoV-2 viral load is associated with increased disease severity and mortality Jesse Fajnzylber, James Regan, Kendyll Coxen, Nature Communications Plasma ViremiaSars-cov-2 Viral LoadViral PersistenceViral DiagnosticsCovid-19 Pandemic	2020	957
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 Tyler N. Starr, Allison J. Greaney, Amin Addetia, Science	2021	841
SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms Sarah A. Clark, Lars E. Clark, Junhua Pan, Cell Viral EvolutionHumoral ResponseViral PathogenesisImmunologyVirology	2021	196
Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation Da‐Yuan Chen, Chue Vin Chin, Devin Kenney, Nature Key DeterminantsCovid-19Synthetic Aperture Radar	2023	126
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 Tyler N. Starr, Allison J. Greaney, Amin Addetia, Viral Evolutionary EscapeViral DiagnosticsViral ImmunityImmunologyViral Pathogenesis	2020	112
Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19) Julie Boucau, Rockib Uddin, Caitlin Marino, Clinical Infectious Diseases Coronavirus Disease 2019Nirmatrelvir-ritonavir TreatmentDiagnostic VirologyViral PersistenceViral Diagnostics	2022	93
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency Yijia Li, Manish C. Choudhary, James Regan, Science Translational Medicine	2024	88
SARS-CoV-2 Virologic Rebound With Nirmatrelvir–Ritonavir Therapy Gregory E. Edelstein, Julie Boucau, Rockib Uddin, Annals of Internal Medicine	2023	64
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection Rinki Deo, Manish C. Choudhary, Carlee Moser, Annals of Internal Medicine	2023	62
Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections Mark J. Siedner, Julie Boucau, Rebecca F. Gilbert, JCI Insight Viral DiagnosticsImmunodeficienciesIsolation GuidelinesDelta VariantVirus Transmission	2021	56

Page 1